Search results for:
ipratropium
ipratropium
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Atrovent HFA |
AEROSOL, INHALATION |
CFC free 17 mcg/inh |
|
|
|
|
| Atrovent |
SOLUTION, INHALATION |
500 mcg/2.5 mL |
|
|
|
|
Last updated: Mar. 3, 2023
- Formulary, Not Routinely Stocked: Atrovent HFA
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
ipratropium (Atrovent HFA) **PRN orders**
ipratropium (Atrovent)
Exceptions --> PRN inhalers to be "kept at bedside" or "self-administered"
ipratropium (Atrovent HFA) **Scheduled orders**
ipratropium (Atrovent)
ipratropium (Atrovent HFA) **acute asthama**
ipratropium (Atrovent) **nebulization**
Common Nebulized Doses for Pediatrics
Reviewed: December 16, 2014 (Atrovent HFA)